Free Trial

NAYA Biosciences (NAYA) Competitors

NAYA Biosciences logo
$1.46 +0.04 (+2.82%)
As of 06/11/2025

NAYA vs. GCTK, HSCS, AMIX, TMDIF, TIVC, VERO, TTOO, IVF, NUWE, and BBLG

Should you be buying NAYA Biosciences stock or one of its competitors? The main competitors of NAYA Biosciences include GlucoTrack (GCTK), Heart Test Laboratories (HSCS), Autonomix Medical (AMIX), Titan Medical (TMDIF), Tivic Health Systems (TIVC), Venus Concept (VERO), T2 Biosystems (TTOO), INVO Fertility (IVF), Nuwellis (NUWE), and Bone Biologics (BBLG). These companies are all part of the "medical equipment" industry.

NAYA Biosciences vs. Its Competitors

GlucoTrack (NASDAQ:GCTK) and NAYA Biosciences (NASDAQ:NAYA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

In the previous week, GlucoTrack had 5 more articles in the media than NAYA Biosciences. MarketBeat recorded 5 mentions for GlucoTrack and 0 mentions for NAYA Biosciences. GlucoTrack's average media sentiment score of 0.78 beat NAYA Biosciences' score of 0.00 indicating that GlucoTrack is being referred to more favorably in the media.

Company Overall Sentiment
GlucoTrack Positive
NAYA Biosciences Neutral

GlucoTrack has a beta of -0.19, suggesting that its stock price is 119% less volatile than the S&P 500. Comparatively, NAYA Biosciences has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500.

NAYA Biosciences has a consensus price target of $24.00, indicating a potential upside of 1,543.84%. Given NAYA Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe NAYA Biosciences is more favorable than GlucoTrack.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GlucoTrack
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NAYA Biosciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

GlucoTrack has higher earnings, but lower revenue than NAYA Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GlucoTrackN/AN/A-$7.10M-$56.600.00
NAYA Biosciences$6.23M0.16-$8.03MN/AN/A

NAYA Biosciences received 1 more outperform votes than GlucoTrack when rated by MarketBeat users.

CompanyUnderperformOutperform
GlucoTrackN/AN/A
NAYA BiosciencesOutperform Votes
1
100.00%
Underperform Votes
No Votes

10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 12.0% of NAYA Biosciences shares are held by institutional investors. 12.9% of GlucoTrack shares are held by insiders. Comparatively, 1.8% of NAYA Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

GlucoTrack has a net margin of 0.00% compared to NAYA Biosciences' net margin of -119.91%. NAYA Biosciences' return on equity of 0.00% beat GlucoTrack's return on equity.

Company Net Margins Return on Equity Return on Assets
GlucoTrackN/A -826.43% -707.26%
NAYA Biosciences -119.91%N/A -41.72%

Summary

NAYA Biosciences beats GlucoTrack on 9 of the 14 factors compared between the two stocks.

Get NAYA Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAYA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAYA vs. The Competition

MetricNAYA BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.22M$4.32B$5.57B$8.50B
Dividend YieldN/A42.67%5.28%4.16%
P/E RatioN/A27.8226.6319.64
Price / Sales0.1668.18407.99152.17
Price / CashN/A51.0838.2534.64
Price / Book-0.715.746.964.60
Net Income-$8.03M$66.95M$3.23B$248.06M
7 Day PerformanceN/A-2.90%-1.13%-0.94%
1 Month Performance-26.26%16.02%8.59%3.52%
1 Year PerformanceN/A18.20%33.63%14.02%

NAYA Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAYA
NAYA Biosciences
N/A$1.46
+2.8%
$24.00
+1,543.8%
N/A$1.22M$6.23M0.0010
GCTK
GlucoTrack
1.3129 of 5 stars
$0.14
-4.5%
N/A-99.8%$3.94MN/A0.005News Coverage
Short Interest ↓
HSCS
Heart Test Laboratories
2.6549 of 5 stars
$3.59
-5.0%
$13.00
+262.1%
-32.8%$3.88M$14.70K-0.4510Short Interest ↑
Gap Down
AMIX
Autonomix Medical
2.6937 of 5 stars
$1.38
-15.9%
$16.50
+1,095.7%
-95.8%$3.84MN/A-0.111Short Interest ↑
Gap Down
High Trading Volume
TMDIF
Titan Medical
N/A$0.28
flat
N/A+546.5%$3.73M$17.63M-0.2250Gap Up
TIVC
Tivic Health Systems
0.4927 of 5 stars
$3.92
-5.5%
N/A-48.0%$3.44M$516K0.0010
VERO
Venus Concept
1.6964 of 5 stars
$2.39
flat
N/A-73.5%$3.40M$61.00M-0.30410Negative News
Short Interest ↓
TTOO
T2 Biosystems
1.8211 of 5 stars
$0.16
-0.4%
$5.00
+3,125.8%
-97.0%$3.26M$7.68M0.00180News Coverage
Short Interest ↑
IVF
INVO Fertility
N/A$1.49
-6.3%
N/AN/A$3.20M$6.59M-0.0410Positive News
NUWE
Nuwellis
3.0698 of 5 stars
$0.61
-20.5%
$17.00
+2,675.5%
-96.0%$2.68M$8.79M-0.0170
BBLG
Bone Biologics
1.442 of 5 stars
$0.81
-2.8%
N/A-49.4%$2.63MN/A0.002Stock Split
Short Interest ↓
Analyst Revision
Gap Down

Related Companies and Tools


This page (NASDAQ:NAYA) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners